Course 1 in Stockholm – week 5, 2027 (3 days)

• Parkinson’s disease
• Basal ganglia patophysiology
• Neurological examination at specialist level
• Medical treatment in the non-fluctuating (incl. side effects (ICD))
• Non-motor symptoms
• Dementia, depression, sleep, autonomic symptoms, psychosis

Course 2 in Oslo week 39, 2027 (2 days)

• Parkinson’s disease
• Paraclinical examination (MRI, PET, SPECT, CSF, blood, urine)
• Medical treatment in the fluctuating patient
• Apomorfin
• Duodopa
• DBS

Course 3 in Copenhagen week 5, 2028 (2 days)

• Dystonia and Tourette
• Clinical and paraclinical examination
• Treatment
• BTX
• DBS

Course 4 in Aarhus week 39, 2028 (2 days)

• Tremor
• Clinical and paraclinical examination
• Medical treatment
• DBS
• MR-FUS

Course 5 in Göteborg week 5, 2029 (3 days)

• Atypical parkinsonism including MSA, PSP, CBS, DLB
• Clinical and paraclinical examination
• Treatment
• Organization

Course 6 in Lund week 39, 2029 (2 days)

• Genetic movement disorder including HD, Ataxia, Wilson and other rare diseases
• Clinical and paraclinical examination
• Genetic counselling

Course 7 in Helsinki week 5, 2030 (2 days)

• Psychogenic movements disorders and acute movements disorders (including paraneoplastic syndromes)
• Clinical and paraclinical examination
• Treatment